Showing 1101-1110 of 1371 results for "".
- FDA Tightens Breast Implant Safety Requirements, Updates Study Resultshttps://modernaesthetics.com/news/fda-tightens-breast-implant-safety-requirements-updates-study-results/2473159/FDA is calling for stronger warnings on breast implants including a boxed warning, which lists such potential risks as infection, rupture, capsular contraction, breast implant illness, and breast implant-associated anaplastic large cell Lymphoma (BIA-ALCL).
- Crown Aesthetics Announces SkinPen Precision Ambassador Program in Celebration Of National Microneedling Dayhttps://modernaesthetics.com/news/crown-aesthetics-announces-skinpen-precision-ambassador-program-in-celebration-of-national-microneedling-day/2473156/Crown Aesthetics announced the launch of their SkinPen Ambassador Program in conjunction with National Microneedling Day. The SkinPen Ambassador Program presents current SkinPen providers with the opportunity to showcase their practice success and to share valuable insights and SkinPen
- Galderma's Restylane Turns 25!https://modernaesthetics.com/news/galdermas-restylane-turns-25/2473147/Galderma’s Restylane is celebrating 25 years on the market. Since launching in Europe in 1996, Restylane has celebrated many milestones across the globe. This includes the first approval for use by the U.S. Food and Drug Administration (FDA) in 2003 and in China by the Nation
- Coming in November: The Science of Skincare Summithttps://modernaesthetics.com/news/coming-in-november-the-science-of-skincare-summit/2473146/A one-day event dedicted to education on skincare for medical and aesthetic professionals in all specialties, the Science of Skincare Summit November 6 at JW Marriott Essex House in New York City. Dermatologists Patti Farris, MD and Ted Lain, MD are co-founders of the program,
- ellacor Maker Cytrellis Closes Funding Roundhttps://modernaesthetics.com/news/ellacor-maker-cytrellis-closes-funding-round/2473145/Cytrellis has closed a $50 million Series C funding round. The financing was led by D1 Capital Partners and included participation from an additional new investor, Sands Capital, as well as existing institutional investors, ARCH Venture Partners and PFM Health Sciences. Proceeds will be
- New Hydrafacial, Epicutis Collab: Epicutis’ Neck & Décoletté Boosterhttps://modernaesthetics.com/news/new-hydrafacial-epicutis-collab-epicutis-neck-decolette-booster/2473144/HydraFacial is partnering with Epicutis to offer a new booster: Epicutis’ Neck & Décoletté Booster. Epicutis’ Neck & Décoletté Booster aims to reduce the wrinkled appearance of the face and neck, combat the appearance of fine lines and wri
- New from Sciton: BBLINK Goggleshttps://modernaesthetics.com/news/new-from-sciton-bblink-goggles/2473142/Sciton Inc. is launching BBLINK Goggles. These smart glasses physically blink for the user to block out strain inducing light flashes, leading to improved treatment visibility and a more pleasant experience for the practitioner. BBLINK Goggles feature proprietary technol
- As Aging Population Increases, Medical Aesthetics Market is Predicted to Growhttps://modernaesthetics.com/news/as-aging-population-increases-medical-aesthetics-market-is-predicted-to-grow/2473135/The global Medical Aesthetics Market, valued at USD 10.1 billion in 2018, is expected to reach USD 20.4 billion in 2026, growing at a CAGR of 9.0% during the forecast period, according to the latest report from All
- Bausch Health Pursues IPO of Solta Medicalhttps://modernaesthetics.com/news/bausch-health-pursues-ipo-of-solta-medical/2473130/Bausch Health Companies Inc. is planning to pursue an initial public offering (IPO) of its Solta Medical business. Solta’s portfolio includes the Thermage RF systems, Fraxel laser, Clear + Brilliant laser and VASER ultrasonic systems. The timing of the anticipated IPO, w
- ellacor from Cytrellis Cleared for Moderate-to-Severe Facial Wrinkleshttps://modernaesthetics.com/news/ellacor-from-cytrellis-cleared-for-moderate-to-severe-facial-wrinkles/2473129/FDA has cleared the ellacor system from Cytrellis for the treatment of moderate-to-severe wrinkles in the mid to lower face. The minimally invasive device, featuring Micro-Coring technology, is a first-in-category device that safely removes micro-sized portions of excess